Perillyl Alcohol in Treating Patients With Refractory Cancer

NCT00002862 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Lymphoma
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: perillyl alcohol

Sponsor

National Cancer Institute (NCI)